However, in both cell and animal neurodegenerative models (Alzheimer’s, Parkinson’s, and Huntington’s diseases), increasing TFAM levels by mild overexpression or enzyme replacement considerably improved neural function and content [300]. Here, TFAM is linked to Parkinson disease.